Birth Control Pills Are Safe For People with Diabetes


birth control pills ok for diabetesPeople with diabetes are often afraid to use hormonal contraceptives such as birth control pills and DMPA injections because they do not want their sugar level to increase. A study revealed an increase in blood sugar does occur, but not worrying.

Hormonal contraceptives are widely used because it is relatively practical and does not reduce the comfort compared to other methods such as condoms. But contraception also has the most side effects, including disruption of the menstrual cycle and black spots on the face.

For people with diabetes, the most worrying side effects of hormonal contraceptive use is the increase in blood sugar levels. Allegedly the hormone used, affect the work of insulin in metabolizing sugar.

Recently, experts from the University of Texas Medical Branch at Galveston did a research, specifically to address these concerns. The study was conducted for 3 years and the results will be published in the Obstetrics and Gynecology journal in January 2011.

Research on hormonal contraception that is claimed as the largest, uses a hormonal contraception in the form of birth control pills and depot medroxyprogesterone acetate (DMPA) injections. The comparison is non-hormonal contraception like condom, periodic abstinence and sterilization.

As a result, injection of DMPA and oral contraceptives did provide increased levels of sugar and insulin in the blood. The increase occurred consistently through the first 30 months of use, with the greatest rate of increase occurred in the first 6 months.

However, researchers said that the increase was not significant enough to aggravate the condition with diabetes. That is, the type of hormonal contraceptives are safe to use despite a disruption in insulin and blood sugar regulation.

“It should be further investigated how the DMPA and birt control pills affects diabetes. But at least, this research could reassure people who already use the contraceptive method,” said Dr. Abbey Berenson of the Center for Interdisciplinary Research in Women’s Health, according to HealthDay.